These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Determining the cutoff value of the APTT mixing test for factor VIII inhibitor. Tang N, Chen Y, Li D, Yin S. Clin Chem Lab Med; 2019 Apr 24; 57(5):e88-e90. PubMed ID: 30367784 [No Abstract] [Full Text] [Related]
27. Disappearance of a high response factor VIII inhibitor in a hemophiliac with AIDS. Leyva WH, Knutsen AP, Joist JH. Am J Clin Pathol; 1988 Mar 24; 89(3):414-8. PubMed ID: 3126644 [Abstract] [Full Text] [Related]
28. FVIII and FIX inhibitors in people living with hemophilia in Cameroon, Africa: a preliminary study. Balôgôg PN, Tagny CT, Ndoumba A, Mbanya D. Int J Lab Hematol; 2014 Oct 24; 36(5):566-70. PubMed ID: 25356499 [Abstract] [Full Text] [Related]
36. Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate. Sultan Y, Brouet JC, Debre P. N Engl J Med; 1974 Nov 14; 291(20):1087. PubMed ID: 4414451 [No Abstract] [Full Text] [Related]
40. Contact activation and factor VII after the use of an activated prothrombin complex concentrate (FEIBA) in hemophiliacs with inhibitors. Mariani G, Bouma BN, Mazzucconi MG, Avvisati G, Di Nucci GD, Corrao D, Mandelli F. Thromb Res; 1983 Aug 01; 31(3):475-88. PubMed ID: 20218003 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]